Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Return on Capital Employed (2016 - 2025)

United Therapeutics (UTHR) has disclosed Return on Capital Employed for 16 consecutive years, with 0.21% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed changed 0.0% to 0.21% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.21% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.21% for FY2025, 0.0% changed from the prior year.
  • Return on Capital Employed hit 0.21% in Q4 2025 for United Therapeutics, roughly flat from 0.21% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.22% in Q2 2024 to a low of 0.08% in Q1 2021.
  • Historically, Return on Capital Employed has averaged 0.18% across 5 years, with a median of 0.18% in 2022.
  • Biggest five-year swings in Return on Capital Employed: dropped -9bps in 2021 and later increased 10bps in 2022.
  • Year by year, Return on Capital Employed stood at 0.12% in 2021, then skyrocketed by 52bps to 0.18% in 2022, then rose by 7bps to 0.19% in 2023, then grew by 12bps to 0.21% in 2024, then dropped by 0bps to 0.21% in 2025.
  • Business Quant data shows Return on Capital Employed for UTHR at 0.21% in Q4 2025, 0.21% in Q3 2025, and 0.2% in Q2 2025.